In the BioHarmony Drug Report Database
Lutropin alfa
Luveris (lutropin alfa) is a protein pharmaceutical. Lutropin alfa was first approved as Luveris on 2000-11-29. It is used to treat female infertility in the USA. It has been approved in Europe to treat female infertility and ovulation induction. The pharmaceutical is active against lutropin-choriogonadotropic hormone receptor.
Trade Name
|
Luveris |
|---|---|
Common Name
|
lutropin alfa |
ChEMBL ID
|
CHEMBL1201419 |
Indication
|
female infertility, ovulation induction |
Drug Class
|
Tricyclic compounds; atropine derivatives |
Image (chem structure or protein)
